EDGAR Filing Documents for 0001104659-23-098031

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001104659-23-098031

Filing Date

2023-09-05

Accepted

2023-09-05 09:00:13

Documents

Period of Report

2023-09-05

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	tm2325455d1_6k.htm	6-K	9489
2	EXHIBIT 99.1	tm2325455d1_ex99-1.htm	EX-99.1	8506
	Complete submission text file	0001104659-23-098031.txt		19182

Mailing Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210

Business Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-36288 | Film No.: 231234260
SIC: 2834 Pharmaceutical Preparations